Atlas Trials

Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel

Clinical trial NCT01687218 · COMPLETED

Trial details

NCT number
NCT01687218
Sponsor
CONRAD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV
Start date
2013-09-25
Primary completion
2015-05-26
Enrollment
195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.